“We are pleased the FDA has declared that supply of the only real, FDA-approved semaglutide medicines is resolved, affirming that Novo Nordisk is meeting or exceeding current and projected nationwide ...
The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker ...
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
Shares of Novo Nordisk (NVO) are up 6% in pre-market trading after a FDA drug shortage notice indicated that a shortage of several versions of ...
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs and comes ...
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback